TMCnet News
Corindus Vascular Robotics, Inc. to Present at Stifel 2014 Healthcare ConferenceWALTHAM, Mass. --(Business Wire)-- Corindus Vascular Robotics, Inc. (OTCQB: CVRS), a leading developer of precision vascular robotics ("Corindus" or the "Company"), announced today that its CEO, David M. Handler, will present at the Stifel 2014 Healthcare Conference on Wednesday, November 19 at 2:25pm EST at the New York Palace Hotel. The presentation will include an overview of the Company, its operations, strategies and prospects. About Corindus Vascular Robotics, Inc. Corindus Vascular Robotics Inc. [OTCQB: CVRS] is a global technology leader in robotic-assisted percutaneous coronary interventions (PCIs). The Company's FDA cleared CorPath 200 System is the first medical device that offers interventional cardiologists PCI (News - Alert) procedure control from a radiation protective interventional cockpit. With the CorPath System, Corindus Vascular Robotics brings robotic precision to PCI procedures to help optimize clinical outcomes and minimize the costs associated with complications through improper stent placement. Corindus stands behind its technology with its unique $1,000 hospital credit "One Stent Program." For additional information, visit www.corindus.com, and follow @CorindusInc.
|
